4cyo
From Proteopedia
(Difference between revisions)
| Line 1: | Line 1: | ||
==Leishmania major N-myristoyltransferase in complex with a hybrid inhibitor (compound 21).== | ==Leishmania major N-myristoyltransferase in complex with a hybrid inhibitor (compound 21).== | ||
| - | <StructureSection load='4cyo' size='340' side='right' caption='[[4cyo]], [[Resolution|resolution]] 1.50Å' scene=''> | + | <StructureSection load='4cyo' size='340' side='right'caption='[[4cyo]], [[Resolution|resolution]] 1.50Å' scene=''> |
== Structural highlights == | == Structural highlights == | ||
| - | <table><tr><td colspan='2'>[[4cyo]] is a 1 chain structure. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=4CYO OCA]. For a <b>guided tour on the structure components</b> use [http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=4CYO FirstGlance]. <br> | + | <table><tr><td colspan='2'>[[4cyo]] is a 1 chain structure with sequence from [http://en.wikipedia.org/wiki/Leima Leima]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=4CYO OCA]. For a <b>guided tour on the structure components</b> use [http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=4CYO FirstGlance]. <br> |
</td></tr><tr id='ligand'><td class="sblockLbl"><b>[[Ligand|Ligands:]]</b></td><td class="sblockDat"><scene name='pdbligand=MG:MAGNESIUM+ION'>MG</scene>, <scene name='pdbligand=MYA:TETRADECANOYL-COA'>MYA</scene>, <scene name='pdbligand=UEK:N-{5-[(3S,4R)-1-[(3R)-3-AMINO-4-(4-CHLOROPHENYL)BUTANOYL]-4-(HYDROXYMETHYL)PYRROLIDIN-3-YL]-2-CHLOROPHENYL}-2-(4-FLUOROPHENYL)ACETAMIDE'>UEK</scene></td></tr> | </td></tr><tr id='ligand'><td class="sblockLbl"><b>[[Ligand|Ligands:]]</b></td><td class="sblockDat"><scene name='pdbligand=MG:MAGNESIUM+ION'>MG</scene>, <scene name='pdbligand=MYA:TETRADECANOYL-COA'>MYA</scene>, <scene name='pdbligand=UEK:N-{5-[(3S,4R)-1-[(3R)-3-AMINO-4-(4-CHLOROPHENYL)BUTANOYL]-4-(HYDROXYMETHYL)PYRROLIDIN-3-YL]-2-CHLOROPHENYL}-2-(4-FLUOROPHENYL)ACETAMIDE'>UEK</scene></td></tr> | ||
<tr id='related'><td class="sblockLbl"><b>[[Related_structure|Related:]]</b></td><td class="sblockDat">[[4cyn|4cyn]], [[4cyp|4cyp]], [[4cyq|4cyq]]</td></tr> | <tr id='related'><td class="sblockLbl"><b>[[Related_structure|Related:]]</b></td><td class="sblockDat">[[4cyn|4cyn]], [[4cyp|4cyp]], [[4cyq|4cyq]]</td></tr> | ||
| Line 25: | Line 25: | ||
</StructureSection> | </StructureSection> | ||
[[Category: Glycylpeptide N-tetradecanoyltransferase]] | [[Category: Glycylpeptide N-tetradecanoyltransferase]] | ||
| + | [[Category: Large Structures]] | ||
| + | [[Category: Leima]] | ||
[[Category: Bell, A S]] | [[Category: Bell, A S]] | ||
[[Category: Brannigan, J A]] | [[Category: Brannigan, J A]] | ||
Revision as of 09:32, 20 March 2019
Leishmania major N-myristoyltransferase in complex with a hybrid inhibitor (compound 21).
| |||||||||||
